NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Rafarma Pharmaceuticals Inc (PINK: RAFA)

 
RAFA Technical Analysis
5
As on 8th Jan 2025 RAFA SHARE Price closed @ 0.11 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 0.20 & Strong Sell for SHORT-TERM with Stoploss of 0.26 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

RAFASHARE Price

Open 0.11 Change Price %
High 0.11 1 Day 0.04 57.14
Low 0.11 1 Week 0.04 57.14
Close 0.11 1 Month 0.01 10.00
Volume 5000 1 Year -0.18 -62.07
52 Week High 0.39 | 52 Week Low 0.03
 
PINK USA Most Active Stocks
HMBL 0.00 %
RDAR 0.00 %
TXGE 3316.21 2.69%
AITX 0.00 %
DPLS 0.00 %
GTVH 0.00 %
PSWW 0.00 %
TSOI 0.00 %
NBRI 0.00 %
APLD 7.27 -4.22%
 
PINK USA Top Gainers Stocks
ANAV 12.05 30025.00%
PRKA 38.00 9400.00%
CGGYY 41.88 6765.57%
BKGM 950.00 6566.67%
GPGC 0.40 3900.00%
DBKSF 0.73 3550.00%
NZERD 0.36 800.00%
LOGQ 0.49 716.67%
MEIL 0.08 700.00%
MMCWF 0.07 600.00%
 
PINK USA Top Losers Stocks
SKLV 0.06 -100.00%
SKLV 0.06 -100.00%
LANZ 0.00 -100.00%
DKLRF 0.85 -100.00%
DKLRF 0.85 -100.00%
XTXXF 0.01 -95.45%
FFVWF 0.01 -94.12%
PTHIF 0.10 -90.91%
PTHIF 0.10 -90.91%
WRRZF 0.02 -90.48%
 
 
RAFA
Daily Charts
RAFA
Intraday Charts
Whats New @
Bazaartrend
RAFA
Free Analysis
 
RAFA Important Levels Intraday
RESISTANCE0.11
RESISTANCE0.11
RESISTANCE0.11
RESISTANCE0.11
RESISTANCE0.11
RESISTANCE0.11
RESISTANCE0.11
RESISTANCE0.11
 
RAFA Forecast May 2025
4th UP Forecast0.36
3rd UP Forecast0.28
2nd UP Forecast0.23
1st UP Forecast0.18
1st DOWN Forecast0.04
2nd DOWN Forecast-0.01
3rd DOWN Forecast-0.06
4th DOWN Forecast-0.14
 
RAFA Weekly Forecast
4th UP Forecast0.26
3rd UP Forecast0.21
2nd UP Forecast0.18
1st UP Forecast0.15
1st DOWN Forecast0.07
2nd DOWN Forecast0.04
3rd DOWN Forecast0.01
4th DOWN Forecast-0.04
 
RAFA Forecast2025
4th UP Forecast0.88
3rd UP Forecast0.63
2nd UP Forecast0.48
1st UP Forecast0.33
1st DOWN Forecast-0.11
2nd DOWN Forecast-0.26
3rd DOWN Forecast-0.41
4th DOWN Forecast-0.66
 
 
RAFA Other Details
Segment EQ
Market Capital 109368128.00
Sector Healthcare
Industry Drug Manufacturers-Specialty & Generic
Offical website >
 
RAFA Address
RAFA
 
RAFA Latest News
 
Your Comments and Response on Rafarma Pharmaceuticals Inc
 
RAFA Business Profile
Rafarma Pharmaceuticals, Inc., a multi-product pharmaceutical company, produces and sells drugs, generic antibiotics, and specialty pharmaceuticals in Russia. It offers cephalosporin-based products, antibiotics of non-ß structure, and anti-cancer drugs in the form of injections, ampulla packaged products, child suspensions, tablets, and capsules. The company also provides drugs for accidental wounds, inflammatory eye diseases, and immunological disorders. The company has a collaboration agreement with PlantEXT Ltd. to research and manufacture the first medical cannabis suppositories for patients suffering from inflammatory bowel disease. Rafarma Pharmaceuticals, Inc. was formerly known as Johnston Acquisition Corp. and changed its name to Rafarma Pharmaceuticals, Inc. in October 2012. The company is based in Sandy, Utah with a manufacturing and distribution facility in Russia. As of October 19, 2020, Rafarma Pharmaceuticals, Inc. operates as a subsidiary of R. & D. Biocogency Laboratories Inc. Ltd. Address: 49 West 9000 South, Sandy, UT, United States, 84070
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service